These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 2457362
1. Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugs. Krumwieh D, Schulz G, Seiler FR. Behring Inst Mitt; 1988 Apr; (82):265-81. PubMed ID: 2457362 [Abstract] [Full Text] [Related]
2. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM. Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933 [Abstract] [Full Text] [Related]
3. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro. Hara H, Namiki M. Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914 [Abstract] [Full Text] [Related]
4. Hematopoietic growth factors: biology and clinical application. Gabrilove JL, Jakubowski A. J Natl Cancer Inst Monogr; 1990 Aug; (10):73-7. PubMed ID: 1693284 [Abstract] [Full Text] [Related]
5. Human recombinant derived IL-3 and GM-CSF in hematopoiesis of normal cynomolgus monkeys. Krumwieh D, Weinmann E, Seiler FR. Behring Inst Mitt; 1988 Aug; (83):250-7. PubMed ID: 3071338 [Abstract] [Full Text] [Related]
12. Cell cycle status of erythroid (BFU-E) progenitor cells from the bone marrows of patients on a clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Cooper S, Vadhan-Raj S. Exp Hematol; 1989 Jun; 17(5):455-9. PubMed ID: 2653858 [Abstract] [Full Text] [Related]
13. Clinical role of granulocyte-macrophage colony-stimulating factor. Mitsuyasu RT, Golde DW. Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875 [Abstract] [Full Text] [Related]
14. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ. Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278 [Abstract] [Full Text] [Related]
15. [Current status of the clinical application of hematopoietic growth factors in oncology]. Karthaus M, Ganser A. Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692 [Abstract] [Full Text] [Related]
16. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF. Geissler D, Niederwieser D, Aulitzky WE, Tilg H, Grünewald K, Huber C, Konwalinka G. Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343 [Abstract] [Full Text] [Related]